Colorectal Cancer with Liver Metastases
What is Colorectal Cancer with Liver Metastases?
Colorectal cancer with liver metastases means cancer that started in the colon or rectum has spread to the liver. This happens when cancer cells break away from the original tumor and travel through the bloodstream to the liver. The liver is the most common site for colorectal cancer to spread because blood from the intestines flows directly to the liver.
About 25% of people with colorectal cancer already have liver metastases at diagnosis. Another 50% may develop liver metastases during their treatment journey. Catching these changes early through blood tests and imaging can help guide treatment decisions and improve outcomes.
While this is a serious condition, many treatment options exist. Modern therapies can shrink tumors, slow disease progression, and improve quality of life. Regular monitoring through blood tests helps doctors track how well treatments are working.
Symptoms
- Abdominal pain or discomfort, especially in the upper right side
- Persistent changes in bowel habits or stool appearance
- Unexplained weight loss without trying
- Fatigue and weakness that does not improve with rest
- Loss of appetite or feeling full quickly
- Jaundice, which is yellowing of the skin and eyes
- Nausea or vomiting
- Abdominal swelling or bloating
- Dark urine or pale stools
- Rectal bleeding or blood in stool
Some people have no symptoms in the early stages of liver metastases. This is why regular monitoring with blood tests is important for anyone with a history of colorectal cancer.
Concerned about Colorectal Cancer with Liver Metastases? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Liver metastases occur when colorectal cancer cells spread from the original tumor site. The cancer cells enter blood vessels in the colon or rectum and travel through the portal vein system directly to the liver. Risk factors for developing metastases include advanced stage at initial diagnosis, poorly differentiated tumors, and lymph node involvement. Certain genetic mutations in the cancer cells can also increase the likelihood of spread.
Lifestyle factors that increase colorectal cancer risk also contribute to metastases risk. These include a diet high in processed meats and low in fiber, physical inactivity, obesity, smoking, and heavy alcohol use. People with inflammatory bowel disease or a family history of colorectal cancer face higher risk as well.
How it's diagnosed
Diagnosing liver metastases typically involves imaging tests like CT scans, MRI, or PET scans. Blood tests play a key role in monitoring disease progression and treatment response. Gamma-Glutamyl Transferase, or GGT, is a liver enzyme that often becomes elevated when colorectal cancer spreads to the liver. Rising GGT levels may signal disease progression or new metastases.
Rite Aid offers GGT testing as part of our flagship blood panel. Regular testing helps you and your doctor track changes over time. Doctors also use tumor markers like CEA, imaging studies, and sometimes liver biopsies to confirm the diagnosis and plan treatment.
Treatment options
- Surgery to remove liver metastases when tumors are limited and accessible
- Chemotherapy to shrink tumors and slow cancer growth throughout the body
- Targeted therapy drugs that attack specific cancer cell mutations
- Immunotherapy to help your immune system recognize and fight cancer cells
- Radiation therapy to treat specific tumor sites
- Liver-directed therapies like radiofrequency ablation or chemoembolization
- Anti-inflammatory diet rich in vegetables, fruits, and omega-3 fatty acids
- Regular physical activity as tolerated to maintain strength and reduce fatigue
- Stress management through meditation, yoga, or counseling
- Avoiding alcohol to protect remaining liver function
- Working closely with an oncology team for personalized treatment plans
Concerned about Colorectal Cancer with Liver Metastases? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
It means cancer cells from the colon or rectum have traveled through the bloodstream to the liver and formed new tumors there. This is called metastatic disease or stage 4 colorectal cancer. The liver is the most common site for colorectal cancer to spread because blood from the intestines flows directly there.
Yes, many people live for years with liver metastases through modern treatments. Survival depends on factors like the number and size of liver tumors, response to treatment, and overall health. Some patients with limited liver metastases can have the tumors surgically removed, which may lead to long-term survival or even cure in select cases.
GGT is a liver enzyme that often rises when cancer spreads to the liver. Regular GGT testing helps doctors track disease progression and see how well treatments are working. Rising levels may indicate growing metastases, while stable or falling levels suggest treatment is helping.
Early liver metastases often cause no symptoms at all. As tumors grow, you may notice upper right abdominal pain, unexplained weight loss, loss of appetite, or fatigue. More advanced disease can cause jaundice, which is yellowing of the skin and eyes. Regular monitoring through blood tests and imaging is important for catching metastases early.
Testing frequency depends on your treatment stage and doctor's recommendations. During active treatment, blood tests may be done every few weeks to months. After treatment, testing every 3 to 6 months is common for the first few years. Regular monitoring helps catch any disease recurrence or progression early when treatment options may be most effective.
Yes, lifestyle changes support your overall health and treatment effectiveness. An anti-inflammatory diet rich in vegetables, fruits, and healthy fats may help reduce inflammation. Regular gentle exercise can reduce fatigue and maintain strength. Avoiding alcohol protects your liver function, and stress management supports your immune system.
Treatment options include surgery to remove tumors, chemotherapy, targeted therapy drugs, and immunotherapy. Liver-directed treatments like radiofrequency ablation can destroy tumors with heat. Your oncologist will recommend a personalized plan based on the number and location of tumors, prior treatments, and your overall health.
Surgery is possible for some patients with limited liver metastases. If tumors are few in number, located in accessible areas, and you are otherwise healthy, removing them may improve survival significantly. Sometimes chemotherapy is given first to shrink tumors before surgery. Your surgical oncologist will determine if you are a candidate.
Doctors often check CEA, a tumor marker that rises with colorectal cancer activity. Liver function tests like ALT, AST, alkaline phosphatase, and bilirubin show how well your liver is working. Complete blood counts monitor for anemia and treatment side effects. Regular comprehensive testing gives a fuller picture of your health status.
Early detection and treatment of the primary colorectal cancer is key. Following your treatment plan closely, including all recommended chemotherapy or radiation, reduces spread risk. Regular surveillance with blood tests and imaging catches any spread early. Maintaining a healthy lifestyle with good nutrition, regular exercise, and avoiding smoking and excess alcohol also supports your body's ability to fight cancer.